aluates Reports

$ 0.0

Automative

Global Joint Viscosupplementation Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: November 2025

Report Code: QYRE-Auto-0L17572

Global Joint Viscosupplementation Market Research Report 2024

BUY CHAPTERS

Global Joint Viscosupplementation Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-0L17572

Report

November 2025

Pages:154

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bioventus

Johnson & Johnson

Stryker

Sanofi

Anika Therapeutics

Roche

Smith & Nephew

Seikagaku

Ferring

LG Chem

Haohai Biological

Shanghai Jingfeng

KalVista

Johnson & Johnson

Smith & Nephew

Joint Viscosupplementation Market

The global Joint Viscosupplementation market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Joint Viscosupplementation leading manufacturers including Zimmer Biomet, Bioventus, Johnson & Johnson, KalVista, Stryker, Sanofi, Anika Therapeutics, Roche, Smith & Nephew, Seikagaku, etc., dominate supply; the top five capture approximately % of global revenue, with Zimmer Biomet leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Joint Viscosupplementation market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Joint Viscosupplementation Market Report

Report Metric	Details
Report Name	Joint Viscosupplementation Market
Segment by Type	Single Injection Triple Injections Five injections
Segment by Application	Hospital Clinic Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zimmer Biomet, Bioventus, Johnson & Johnson, KalVista, Stryker, Sanofi, Anika Therapeutics, Roche, Smith & Nephew, Seikagaku, Ferring, LG Chem, Haohai Biological, Shanghai Jingfeng
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Joint Viscosupplementation study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Joint Viscosupplementation Market report?

Ans: The main players in the Joint Viscosupplementation Market are Zimmer Biomet, Bioventus, Johnson & Johnson, KalVista, Stryker, Sanofi, Anika Therapeutics, Roche, Smith & Nephew, Seikagaku, Ferring, LG Chem, Haohai Biological, Shanghai Jingfeng

What are the Application segmentation covered in the Joint Viscosupplementation Market report?

Ans: The Applications covered in the Joint Viscosupplementation Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Joint Viscosupplementation Market report?

Ans: The Types covered in the Joint Viscosupplementation Market report are Single Injection, Triple Injections, Five injections

1 Study Coverage

1.1 Introduction to Joint Viscosupplementation: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Joint Viscosupplementation Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Single Injection

1.2.3 Triple Injections

1.2.4 Five injections

1.3 Market Segmentation by Application

1.3.1 Global Joint Viscosupplementation Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Joint Viscosupplementation Revenue Estimates and Forecasts 2020-2031

2.2 Global Joint Viscosupplementation Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Joint Viscosupplementation Sales Estimates and Forecasts 2020-2031

2.4 Global Joint Viscosupplementation Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Joint Viscosupplementation Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Joint Viscosupplementation Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Single Injection Market Size by Manufacturers

3.5.2 Triple Injections Market Size by Manufacturers

3.5.3 Five injections Market Size by Manufacturers

3.6 Global Joint Viscosupplementation Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Joint Viscosupplementation Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Joint Viscosupplementation Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Joint Viscosupplementation Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Joint Viscosupplementation Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Joint Viscosupplementation Sales and Revenue by Type (2020-2031)

6.4 North America Joint Viscosupplementation Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Joint Viscosupplementation Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Joint Viscosupplementation Sales and Revenue by Type (2020-2031)

7.4 Europe Joint Viscosupplementation Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Joint Viscosupplementation Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Joint Viscosupplementation Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Joint Viscosupplementation Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Joint Viscosupplementation Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Joint Viscosupplementation Sales and Revenue by Type (2020-2031)

9.4 Central and South America Joint Viscosupplementation Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Joint Viscosupplementation Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Joint Viscosupplementation Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Joint Viscosupplementation Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Joint Viscosupplementation Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Zimmer Biomet

11.1.1 Zimmer Biomet Corporation Information

11.1.2 Zimmer Biomet Business Overview

11.1.3 Zimmer Biomet Joint Viscosupplementation Product Models, Descriptions and Specifications

11.1.4 Zimmer Biomet Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Zimmer Biomet Joint Viscosupplementation Sales by Product in 2024

11.1.6 Zimmer Biomet Joint Viscosupplementation Sales by Application in 2024

11.1.7 Zimmer Biomet Joint Viscosupplementation Sales by Geographic Area in 2024

11.1.8 Zimmer Biomet Joint Viscosupplementation SWOT Analysis

11.1.9 Zimmer Biomet Recent Developments

11.2 Bioventus

11.2.1 Bioventus Corporation Information

11.2.2 Bioventus Business Overview

11.2.3 Bioventus Joint Viscosupplementation Product Models, Descriptions and Specifications

11.2.4 Bioventus Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Bioventus Joint Viscosupplementation Sales by Product in 2024

11.2.6 Bioventus Joint Viscosupplementation Sales by Application in 2024

11.2.7 Bioventus Joint Viscosupplementation Sales by Geographic Area in 2024

11.2.8 Bioventus Joint Viscosupplementation SWOT Analysis

11.2.9 Bioventus Recent Developments

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Corporation Information

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Joint Viscosupplementation Product Models, Descriptions and Specifications

11.3.4 Johnson & Johnson Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Johnson & Johnson Joint Viscosupplementation Sales by Product in 2024

11.3.6 Johnson & Johnson Joint Viscosupplementation Sales by Application in 2024

11.3.7 Johnson & Johnson Joint Viscosupplementation Sales by Geographic Area in 2024

11.3.8 Johnson & Johnson Joint Viscosupplementation SWOT Analysis

11.3.9 Johnson & Johnson Recent Developments

11.4 KalVista

11.4.1 KalVista Corporation Information

11.4.2 KalVista Business Overview

11.4.3 KalVista Joint Viscosupplementation Product Models, Descriptions and Specifications

11.4.4 KalVista Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 KalVista Joint Viscosupplementation Sales by Product in 2024

11.4.6 KalVista Joint Viscosupplementation Sales by Application in 2024

11.4.7 KalVista Joint Viscosupplementation Sales by Geographic Area in 2024

11.4.8 KalVista Joint Viscosupplementation SWOT Analysis

11.4.9 KalVista Recent Developments

11.5 Stryker

11.5.1 Stryker Corporation Information

11.5.2 Stryker Business Overview

11.5.3 Stryker Joint Viscosupplementation Product Models, Descriptions and Specifications

11.5.4 Stryker Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Stryker Joint Viscosupplementation Sales by Product in 2024

11.5.6 Stryker Joint Viscosupplementation Sales by Application in 2024

11.5.7 Stryker Joint Viscosupplementation Sales by Geographic Area in 2024

11.5.8 Stryker Joint Viscosupplementation SWOT Analysis

11.5.9 Stryker Recent Developments

11.6 Sanofi

11.6.1 Sanofi Corporation Information

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Joint Viscosupplementation Product Models, Descriptions and Specifications

11.6.4 Sanofi Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Sanofi Recent Developments

11.7 Anika Therapeutics

11.7.1 Anika Therapeutics Corporation Information

11.7.2 Anika Therapeutics Business Overview

11.7.3 Anika Therapeutics Joint Viscosupplementation Product Models, Descriptions and Specifications

11.7.4 Anika Therapeutics Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Anika Therapeutics Recent Developments

11.8 Roche

11.8.1 Roche Corporation Information

11.8.2 Roche Business Overview

11.8.3 Roche Joint Viscosupplementation Product Models, Descriptions and Specifications

11.8.4 Roche Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Roche Recent Developments

11.9 Smith & Nephew

11.9.1 Smith & Nephew Corporation Information

11.9.2 Smith & Nephew Business Overview

11.9.3 Smith & Nephew Joint Viscosupplementation Product Models, Descriptions and Specifications

11.9.4 Smith & Nephew Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Smith & Nephew Recent Developments

11.10 Seikagaku

11.10.1 Seikagaku Corporation Information

11.10.2 Seikagaku Business Overview

11.10.3 Seikagaku Joint Viscosupplementation Product Models, Descriptions and Specifications

11.10.4 Seikagaku Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Seikagaku Recent Developments

11.11 Ferring

11.11.1 Ferring Corporation Information

11.11.2 Ferring Business Overview

11.11.3 Ferring Joint Viscosupplementation Product Models, Descriptions and Specifications

11.11.4 Ferring Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Ferring Recent Developments

11.12 LG Chem

11.12.1 LG Chem Corporation Information

11.12.2 LG Chem Business Overview

11.12.3 LG Chem Joint Viscosupplementation Product Models, Descriptions and Specifications

11.12.4 LG Chem Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 LG Chem Recent Developments

11.13 Haohai Biological

11.13.1 Haohai Biological Corporation Information

11.13.2 Haohai Biological Business Overview

11.13.3 Haohai Biological Joint Viscosupplementation Product Models, Descriptions and Specifications

11.13.4 Haohai Biological Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Haohai Biological Recent Developments

11.14 Shanghai Jingfeng

11.14.1 Shanghai Jingfeng Corporation Information

11.14.2 Shanghai Jingfeng Business Overview

11.14.3 Shanghai Jingfeng Joint Viscosupplementation Product Models, Descriptions and Specifications

11.14.4 Shanghai Jingfeng Joint Viscosupplementation Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 Shanghai Jingfeng Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Joint Viscosupplementation Industry Chain

12.2 Joint Viscosupplementation Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Joint Viscosupplementation Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Joint Viscosupplementation Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Joint Viscosupplementation Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Joint Viscosupplementation Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Bioventus

Johnson & Johnson

Stryker

Sanofi

Anika Therapeutics

Roche

Smith & Nephew

Seikagaku

Ferring

LG Chem

Haohai Biological

Shanghai Jingfeng

KalVista

Johnson & Johnson

Smith & Nephew

List of Tables

Table 1. Global Joint Viscosupplementation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Joint Viscosupplementation Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Joint Viscosupplementation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Joint Viscosupplementation Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Joint Viscosupplementation Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Joint Viscosupplementation Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Joint Viscosupplementation Sales by Region (2020-2025) & (K Units)

Table 8. Global Joint Viscosupplementation Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Joint Viscosupplementation Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Joint Viscosupplementation Sales Share by Manufacturers (2020-2025)

Table 12. Global Joint Viscosupplementation Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Joint Viscosupplementation Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Joint Viscosupplementation by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Joint Viscosupplementation as of 2024)

Table 16. Global Joint Viscosupplementation Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Joint Viscosupplementation Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Joint Viscosupplementation Manufacturing Base and Headquarters

Table 19. Global Joint Viscosupplementation Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Joint Viscosupplementation Sales by Type (2020-2025) & (K Units)

Table 23. Global Joint Viscosupplementation Sales by Type (2026-2031) & (K Units)

Table 24. Global Joint Viscosupplementation Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Joint Viscosupplementation Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Joint Viscosupplementation ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Joint Viscosupplementation Sales by Application (2020-2025) & (K Units)

Table 29. Global Joint Viscosupplementation Sales by Application (2026-2031) & (K Units)

Table 30. Joint Viscosupplementation High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Joint Viscosupplementation Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Joint Viscosupplementation Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Joint Viscosupplementation ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Joint Viscosupplementation Growth Accelerators and Market Barriers

Table 37. North America Joint Viscosupplementation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Joint Viscosupplementation Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Joint Viscosupplementation Growth Accelerators and Market Barriers

Table 40. Europe Joint Viscosupplementation Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Joint Viscosupplementation Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Joint Viscosupplementation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Joint Viscosupplementation Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Joint Viscosupplementation Growth Accelerators and Market Barriers

Table 45. Southeast Asia Joint Viscosupplementation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Joint Viscosupplementation Investment Opportunities and Key Challenges

Table 47. Central and South America Joint Viscosupplementation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Joint Viscosupplementation Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Joint Viscosupplementation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Zimmer Biomet Corporation Information

Table 51. Zimmer Biomet Description and Major Businesses

Table 52. Zimmer Biomet Product Models, Descriptions and Specifications

Table 53. Zimmer Biomet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Zimmer Biomet Sales Value Proportion by Product in 2024

Table 55. Zimmer Biomet Sales Value Proportion by Application in 2024

Table 56. Zimmer Biomet Sales Value Proportion by Geographic Area in 2024

Table 57. Zimmer Biomet Joint Viscosupplementation SWOT Analysis

Table 58. Zimmer Biomet Recent Developments

Table 59. Bioventus Corporation Information

Table 60. Bioventus Description and Major Businesses

Table 61. Bioventus Product Models, Descriptions and Specifications

Table 62. Bioventus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Bioventus Sales Value Proportion by Product in 2024

Table 64. Bioventus Sales Value Proportion by Application in 2024

Table 65. Bioventus Sales Value Proportion by Geographic Area in 2024

Table 66. Bioventus Joint Viscosupplementation SWOT Analysis

Table 67. Bioventus Recent Developments

Table 68. Johnson & Johnson Corporation Information

Table 69. Johnson & Johnson Description and Major Businesses

Table 70. Johnson & Johnson Product Models, Descriptions and Specifications

Table 71. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Johnson & Johnson Sales Value Proportion by Product in 2024

Table 73. Johnson & Johnson Sales Value Proportion by Application in 2024

Table 74. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024

Table 75. Johnson & Johnson Joint Viscosupplementation SWOT Analysis

Table 76. Johnson & Johnson Recent Developments

Table 77. KalVista Corporation Information

Table 78. KalVista Description and Major Businesses

Table 79. KalVista Product Models, Descriptions and Specifications

Table 80. KalVista Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. KalVista Sales Value Proportion by Product in 2024

Table 82. KalVista Sales Value Proportion by Application in 2024

Table 83. KalVista Sales Value Proportion by Geographic Area in 2024

Table 84. KalVista Joint Viscosupplementation SWOT Analysis

Table 85. KalVista Recent Developments

Table 86. Stryker Corporation Information

Table 87. Stryker Description and Major Businesses

Table 88. Stryker Product Models, Descriptions and Specifications

Table 89. Stryker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Stryker Sales Value Proportion by Product in 2024

Table 91. Stryker Sales Value Proportion by Application in 2024

Table 92. Stryker Sales Value Proportion by Geographic Area in 2024

Table 93. Stryker Joint Viscosupplementation SWOT Analysis

Table 94. Stryker Recent Developments

Table 95. Sanofi Corporation Information

Table 96. Sanofi Description and Major Businesses

Table 97. Sanofi Product Models, Descriptions and Specifications

Table 98. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Sanofi Recent Developments

Table 100. Anika Therapeutics Corporation Information

Table 101. Anika Therapeutics Description and Major Businesses

Table 102. Anika Therapeutics Product Models, Descriptions and Specifications

Table 103. Anika Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Anika Therapeutics Recent Developments

Table 105. Roche Corporation Information

Table 106. Roche Description and Major Businesses

Table 107. Roche Product Models, Descriptions and Specifications

Table 108. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Roche Recent Developments

Table 110. Smith & Nephew Corporation Information

Table 111. Smith & Nephew Description and Major Businesses

Table 112. Smith & Nephew Product Models, Descriptions and Specifications

Table 113. Smith & Nephew Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Smith & Nephew Recent Developments

Table 115. Seikagaku Corporation Information

Table 116. Seikagaku Description and Major Businesses

Table 117. Seikagaku Product Models, Descriptions and Specifications

Table 118. Seikagaku Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Seikagaku Recent Developments

Table 120. Ferring Corporation Information

Table 121. Ferring Description and Major Businesses

Table 122. Ferring Product Models, Descriptions and Specifications

Table 123. Ferring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Ferring Recent Developments

Table 125. LG Chem Corporation Information

Table 126. LG Chem Description and Major Businesses

Table 127. LG Chem Product Models, Descriptions and Specifications

Table 128. LG Chem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. LG Chem Recent Developments

Table 130. Haohai Biological Corporation Information

Table 131. Haohai Biological Description and Major Businesses

Table 132. Haohai Biological Product Models, Descriptions and Specifications

Table 133. Haohai Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. Haohai Biological Recent Developments

Table 135. Shanghai Jingfeng Corporation Information

Table 136. Shanghai Jingfeng Description and Major Businesses

Table 137. Shanghai Jingfeng Product Models, Descriptions and Specifications

Table 138. Shanghai Jingfeng Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. Shanghai Jingfeng Recent Developments

Table 140. Key Raw Materials Distribution

Table 141. Raw Materials Key Suppliers

Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 143. Milestones in Production Technology Evolution

Table 144. Distributors List

Table 145. Market Trends and Market Evolution

Table 146. Market Drivers and Opportunities

Table 147. Market Challenges, Risks, and Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Joint Viscosupplementation Product Picture

Figure 2. Global Joint Viscosupplementation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Single Injection Product Picture

Figure 4. Triple Injections Product Picture

Figure 5. Five injections Product Picture

Figure 6. Global Joint Viscosupplementation Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Hospital

Figure 8. Clinic

Figure 9. Others

Figure 10. Joint Viscosupplementation Report Years Considered

Figure 11. Global Joint Viscosupplementation Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 13. Global Joint Viscosupplementation Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Joint Viscosupplementation Revenue Market Share by Region (2020-2031)

Figure 15. Global Joint Viscosupplementation Sales (2020-2031) & (K Units)

Figure 16. Global Joint Viscosupplementation Sales (CAGR) by Region (2020-2031) (K Units)

Figure 17. Global Joint Viscosupplementation Sales Market Share by Region (2020-2031)

Figure 18. Top 5 and Top 10 Manufacturers Joint Viscosupplementation Sales Volume Market Share in 2024

Figure 19. Global Joint Viscosupplementation Revenue Market Share Ranking (2024)

Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 21. Single Injection Revenue Market Share by Manufacturer in 2024

Figure 22. Triple Injections Revenue Market Share by Manufacturer in 2024

Figure 23. Five injections Revenue Market Share by Manufacturer in 2024

Figure 24. Global Joint Viscosupplementation Sales Market Share by Type (2020-2031)

Figure 25. Global Joint Viscosupplementation Revenue Market Share by Type (2020-2031)

Figure 26. Global Joint Viscosupplementation Sales Market Share by Application (2020-2031)

Figure 27. Global Joint Viscosupplementation Revenue Market Share by Application (2020-2031)

Figure 28. North America Joint Viscosupplementation Sales YoY (2020-2031) & (K Units)

Figure 29. North America Joint Viscosupplementation Revenue YoY (2020-2031) & (US$ Million)

Figure 30. North America Top 5 Manufacturers Joint Viscosupplementation Sales Revenue (US$ Million) in 2024

Figure 31. North America Joint Viscosupplementation Sales Volume (K Units) by Type (2020- 2031)

Figure 32. North America Joint Viscosupplementation Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 33. North America Joint Viscosupplementation Sales Volume (K Units) by Application (2020-2031)

Figure 34. North America Joint Viscosupplementation Sales Revenue (US$ Million) by Application (2020-2031)

Figure 35. US Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 36. Canada Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 37. Mexico Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 38. Europe Joint Viscosupplementation Sales YoY (2020-2031) & (K Units)

Figure 39. Europe Joint Viscosupplementation Revenue YoY (2020-2031) & (US$ Million)

Figure 40. Europe Top 5 Manufacturers Joint Viscosupplementation Sales Revenue (US$ Million) in 2024

Figure 41. Europe Joint Viscosupplementation Sales Volume (K Units) by Type (2020-2031)

Figure 42. Europe Joint Viscosupplementation Sales Revenue (US$ Million) by Type (2020-2031)

Figure 43. Europe Joint Viscosupplementation Sales Volume (K Units) by Application (2020-2031)

Figure 44. Europe Joint Viscosupplementation Sales Revenue (US$ Million) by Application (2020-2031)

Figure 45. Germany Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 46. France Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 47. U.K. Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 48. Italy Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 49. Russia Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Joint Viscosupplementation Sales YoY (2020-2031) & (K Units)

Figure 51. Asia-Pacific Joint Viscosupplementation Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Asia-Pacific Top 8 Manufacturers Joint Viscosupplementation Sales Revenue (US$ Million) in 2024

Figure 53. Asia-Pacific Joint Viscosupplementation Sales Volume (K Units) by Type (2020- 2031)

Figure 54. Asia-Pacific Joint Viscosupplementation Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 55. Asia-Pacific Joint Viscosupplementation Sales Volume (K Units) by Application (2020-2031)

Figure 56. Asia-Pacific Joint Viscosupplementation Sales Revenue (US$ Million) by Application (2020-2031)

Figure 57. Indonesia Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 58. Japan Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 59. South Korea Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 60. China Taiwan Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 61. India Joint Viscosupplementation Revenue (2020-2031) & (US$ Million)

Figure 62. Central and South America Joint Viscosupplementation Sales YoY (2020-2031) & (K Units)

Figure 63. Central and South America Joint Viscosupplementation Revenue YoY (2020-2031) & (US$ Million)

Figure 64. Central and South America Top 5 Manufacturers Joint Viscosupplementation Sales Revenue (US$ Million) in 2024

Figure 65. Central and South America Joint Viscosupplementation Sales Volume (K Units) by Type (2021-2031)

Figure 66. Central and South America Joint Viscosupplementation Sales Revenue (US$ Million) by Type (2020-2031)

Figure 67. Central and South America Joint Viscosupplementation Sales Volume (K Units) by Application (2020-2031)

Figure 68. Central and South America Joint Viscosupplementation Sales Revenue (US$ Million) by Application (2020-2031)

Figure 69. Brazil Joint Viscosupplementation Revenue (2020-2025) & (US$ Million)

Figure 70. Argentina Joint Viscosupplementation Revenue (2020-2025) & (US$ Million)

Figure 71. Middle East, and Africa Joint Viscosupplementation Sales YoY (2020-2031) & (K Units)

Figure 72. Middle East and Africa Joint Viscosupplementation Revenue YoY (2020-2031) & (US$ Million)

Figure 73. Middle East and Africa Top 5 Manufacturers Joint Viscosupplementation Sales Revenue (US$ Million) in 2024

Figure 74. Middle East and Africa Joint Viscosupplementation Sales Volume (K Units) by Type (2021-2031)

Figure 75. South America Joint Viscosupplementation Sales Revenue (US$ Million) by Type (2020-2031)

Figure 76. Middle East and Africa Joint Viscosupplementation Sales Volume (K Units) by Application (2020-2031)

Figure 77. Middle East and Africa Joint Viscosupplementation Sales Revenue (US$ Million) by Application (2020-2031)

Figure 78. GCC Countries Joint Viscosupplementation Revenue (2020-2025) & (US$ Million)

Figure 79. Turkey Joint Viscosupplementation Revenue (2020-2025) & (US$ Million)

Figure 80. Egypt Joint Viscosupplementation Revenue (2020-2025) & (US$ Million)

Figure 81. South Africa Joint Viscosupplementation Revenue (2020-2025) & (US$ Million)

Figure 82. Joint Viscosupplementation Industry Chain Mapping

Figure 83. Regional Joint Viscosupplementation Manufacturing Base Distribution (%)

Figure 84. Global Joint Viscosupplementation Production Market Share by Region (2020-2031)

Figure 85. Joint Viscosupplementation Production Process

Figure 86. Regional Joint Viscosupplementation Production Cost Structure

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Single Injection Hyaluronic Acid Viscosupplement Market Research Report 2024

Global Industrial Viscometers Market Research Report 2025

Global Viscosity Modifying Agents Market Research Report 2025

Global High Viscosity Pumps Market Research Report 2024

Global High Viscosity Reactor Market Research Report 2025

Global Joint Compound Market Research Report 2024

Global Viscosity Cup Market Research Report 2025

Global Universal Joint Market Research Report 2024

Global Viscofill Machine Market Research Report 2025

Global Rheometer and Viscometer Market Research Report 2025

Global Rotary Viscometer Market Insights Forecast to 2030

Global Expansion Joint Market Research Report 2025

Global Orthopaedic Viscoelastic Supplement Market Research Report 2024

Global Flow Cup Viscometer Market Research Report 2025

Global High Shear Viscometer Market Research Report 2025

Global Linen Viscose Market Research Report 2024

Global Capillary Tube Viscometers Market Research Report 2025

High Viscosity Rotary Pump Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Acid Viscosifier Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions